Clinical Trial Update: Early iNO for Oxidative Stress, Vascular Tone and Inflammation in Babies With Hypoxic Respiratory Failure [Phase 4]

View source ↗

Summary

Clinical trial investigating early inhaled nitric oxide for oxidative stress and inflammation in newborns with respiratory failure was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension Pulmonary of Newborn Persistent
• Persistent Fetal Circulation Syndrome
• Persistent Pulmonary Hypertension of the Newborn

Snippet

Sponsor: University of Florida | Conditions: Persistent Fetal Circulation Syndrome, Hypertension, Pulmonary, of Newborn, Persistent | Phase 4 | Status: WITHDRAWN